Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer

August 27, 2024 4:05 PM

Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has appointed Kevin Williamson as Chief Financial Officer. Mr. Williamson's appointment succeeds the previously disclosed retirement of Steve Van Dick from the role of Chief Financial Officer.Mr. Williamson most recently served as the Chief Financial...

Read more

Albert Plastic Surgery's Revolutionary Closed Rhinoplasty Procedure

August 27, 2024 3:00 PM

A Global Approach for All Primary and Revision CasesNEW YORK, NY / ACCESSWIRE / August 27, 2024 / Contrary to some surgeons' views of traditional closed or endonasal approaches, the limited incision closed rhinoplasty technique can be reliably employed for all rhinoplasty cases regardless of their complexity. With a resurgence of interest from the public in scarless and preservation nose surgery, Albert Plastic Surgery's innovative closed...

Read more

Raise the Woof at VRCCO's Second Annual Benefit Gala

August 27, 2024 1:30 PM

Join an Evening of Fun, Food and Fundraising on September 21, 2024BEND, OR / ACCESSWIRE / August 27, 2024 / The Veterinary Referral Center of Central Oregon is back to Raise the Woof in 2024 at their second annual benefit gala, an evening of purpose celebrating Bend's valued pet community and supporting VRCCO's philanthropic fund initiatives. This event will take place on Saturday, September 21, 2024, from 5:00 p.m.-9:00 p.m. at the Unitarian...

Read more

Tennesseans With Intellectual and Developmental Disabilities Aren't Getting Dental Treatment. What Needs to Change?

August 27, 2024 1:00 PM

AIDPH and Harmony Health assess oral health barriersRIVER FOREST, IL / ACCESSWIRE / August 27, 2024 / Tennesseans with intellectual and developmental disabilities (IDD) face excessive wait times for dental appointments and higher rates of tooth extraction, according to a new report by the American Institute of Dental Public Health (AIDPH) and Harmony Health.Funded by the Tennessee Department of Disability and Aging, "The Landscape of Dental Care...

Read more

Quest Career Progression: Blair Rule

August 27, 2024 12:00 PM

NORTHAMPTON, MA / ACCESSWIRE / August 27, 2024 / Quest Diagnostics From entry-level phlebotomist to Manager, Field Operations18 years at QuestSouthwest Region - Oklahoma City, OklahomaQ: What did you initially want out of your career?Blair: When I first started with Quest, I was looking for a stable job that I enjoyed doing. I worked in the restaurant industry and childcare prior to taking a role with Quest and while I loved those jobs, they...

Read more

TramutoPorter Foundation Celebrates Compassionate Leadership Week with the Launch of Camp Sunshine

August 27, 2024 11:45 AM

The TramutoPorter Foundation, in partnership with Camp Sunshine, is thrilled to announce the successful launch of the first-ever Camp Sunshine week dedicated to children and their families who have experienced hearing loss due to life-threatening illnesses. This inaugural event marks a significant milestone in our ongoing commitment to providing support and bringing joy to families facing significant health challenges.Recognized globally as...

Read more

Bruder Healthcare Introduces Eyeleve MGD, a Trusted Eye Drop Formula Under a New Brand

August 27, 2024 11:15 AM

With 80 percent of dry eye patients suffering from evaporative dry eye, Eyeleve MGD will serve a crucial need of patients and practitioners alike.ATLANTA, GA / ACCESSWIRE / August 27, 2024 / Bruder Healthcare, a Hilco Vision Company, is pleased to announce that it has entered into an exclusive distribution agreement with Santen S.A. to market Eyeleve® MGD in the United States. To be marketed in early 2025 as Eyeleve® MGD, the eye drop...

Read more

Unlocking Curiosity in St. Louis With MilliporeSigma's Curiosity Cube

August 27, 2024 11:00 AM

NORTHAMPTON, MA / ACCESSWIRE / August 27, 2024 / With more than 2,000 employees and eight facilities in St. Louis, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is committed to inspiring the STEM talent of the future. To help increase interest in STEM for students across St. Louis, MilliporeSigma enhanced its Curiosity Cube, which resides at the company's Laclede facility, with an updated look and...

Read more

Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting

August 27, 2024 10:15 AM

MorphoSys AG today announced that its shareholders approved all resolutions proposed by the company's Management Board and Supervisory Board at its 2024 Annual General Meeting. This included the transfer of MorphoSys' minority shareholders' shares to Novartis BidCo Germany AG (hereinafter referred to as "Novartis"), the company's majority shareholder, against a cash compensation of € 68.00 per share ("merger squeeze-out"). The merger squeeze-out...

Read more

New LiverAdvocates.org Website Launches With Fatty Liver Risk Assessment Quiz

August 27, 2024 10:00 AM

NASH kNOWledge redesigns website; introduces new URL as 6-year anniversary approachesPITTSBURGH, PA / ACCESSWIRE / August 27, 2024 / NASH kNOWledge today announces a refreshed website and new URL to make it easier for fatty liver disease patients, caregivers and medical professionals to access the wide array of resources available for free, including a Fatty Liver Risk Assessment quiz. Liver transplant and cancer survivor Tony Villiotti founded...

Read more

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)

August 27, 2024 10:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / August 27, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that the country of Jordan's Industrial Property Protection Directorate has issued a new patent to Jaguar family company Napo Pharmaceuticals (Napo) for methods for treating short bowel syndrome (SBS), bile acid diarrhea, and diarrhea associated with small intestine resection or gallbladder removal, in patients with an inhibitor of...

Read more

Move Up ABA Revolutionizes Autism Care With Personalized In-Home ABA Therapy Services in Maryland

August 27, 2024 10:00 AM

Move Up ABA Redefines Autism Care in Maryland with Groundbreaking In-Home Therapy ServicesBALTIMORE, MD / ACCESSWIRE / August 27, 2024 / Move Up ABA, a leading provider of Applied Behavior Analysis (ABA) therapy, is transforming autism care in Maryland by offering highly personalized, in-home ABA therapy services for children and young adults aged 1-21. With a commitment to clinical excellence and a no-waitlist policy, Move Up ABA is setting new...

Read more

CLS Health Celebrates Dr. Maamoun Harmouch’s Milestone of Over 1,500 Robotic Surgeries with the Da Vinci Surgery System

August 27, 2024 9:30 AM

HOUSTON, TX / ACCESSWIRE / August 27, 2024 / Colorectal surgeon Maamoun Harmouch, M.D., of CLS Health, has successfully performed over 1,500 robotic surgeries, making him one of the most experienced robotic surgeons in Houston. According to the American College of Surgeons, the average surgeon typically performs around 50-100 robotic surgeries annually. In the past two years alone, Dr. Harmouch completed over 1,000 robotic surgeries,...

Read more

First Results from Lexaria's Second GLP-1 Human Pilot Study

August 27, 2024 9:20 AM

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that the first results from human pilot study #2, GLP-1-H24-2 (the "Study"), have been received. Lexaria's DehydraTECH®-processed Rybelsus® evidenced a trend toward higher overall absorption compared to Rybelsus® that was not processed with DehydraTECH.Since Lexaria has already demonstrated superior...

Read more

Cantargia Reports Presentation of New Preclinical Data Supporting CAN10 in Fibrotic Lung Diseases

August 27, 2024 9:15 AM

LUND, SWEDEN / ACCESSWIRE / August 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported presentation of new preclinical data providing support for CAN10 as a potential treatment of fibrotic lung diseases. The new data shows upregulation of the CAN10 target protein IL1RAP in lungs from patients with systemic sclerosis associated interstitial lung disease (SSc-ILD) and idiopathic pulmonary fibrosis...

Read more

“The Adventure Jar,” Showcases a Family Navigating the Challenges of a Cancer Diagnosis and Finding Magic in Time Together

August 27, 2024 9:15 AM

NORTHAMPTON, MA / ACCESSWIRE / August 27, 2024 / Gilead Sciences:Cancer can cause disruption for families and may especially impact children. "The Adventure Jar," created by Gilead in partnership with the metastatic breast cancer community, showcases the perspective of one family navigating the challenges of a diagnosis and finding magic in time together. This book is part of our ongoing commitment to provide resources and support for people...

Read more

CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

August 27, 2024 9:10 AM

Live webcast on Wednesday, August 28th at 3:20 PM ETHOUSTON, TX / ACCESSWIRE / August 27, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals, will present and discuss recent...

Read more

Spine Pain Market is Expected to Reach USD 13.08 Billion by 2034 and growing at a CAGR of 5% | FMI Inc.

August 27, 2024 8:30 AM

The spine pain market is predicted to be valued at USD 8.03 billion by 2024. The lower back pain market size is estimated to be USD 13.08 billion by 2034, projected at a CAGR of 5%.The surge in the prevalence of spine-related conditions, fueled by aging populations, sedentary lifestyles, and obesity, acts as a primary driver for industrial expansion.Technological advancements in diagnostics, imaging, and minimally invasive surgical procedures...

Read more

Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference

August 27, 2024 8:30 AM

Company invites shareholders and all interested parties to learn our journey for ultimately becoming AI's nose capable of digitizing smell.SAN DIEGO, CA / ACCESSWIRE / August 27, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), a diversified healthcare company focused on novel AI-powered point-of-care testing ("POCT") and VELDONA low-dose interferon therapeutics, today announced that it will be attending the H.C....

Read more

PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection

August 27, 2024 8:00 AM

PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing treatments for neurological disorders, is pleased to announce a significant milestone in its global health efforts. The Malawi Ministry of Health has informed the company that a patient suffering from the potentially fatal parasitic infection known as Human Africa Trypanosomiasis Brucei Rhodesiense, (HAT), commonly referred to as African Sleeping...

Read more